Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this warning letter was issued to Nartex Laboratorios Homeopaticos S.A. de C.V., a homeopathic drug manufacturer, on November 4, 2020. The FDA identified regulatory violations related to drug products, though the specific nature of the violations cannot be determined from the available metadata. Without access to the complete letter text or detailed subject information, the exact compliance issues and their scope remain unclear, though they fall under FDA's jurisdiction over drug manufacturing and distribution.